Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMC

IMPAIRMENT OF MITOCHONDRIAL FUNCTION IN MURINE SEPSIS SURVIVORS

Steele A., Starr M., Patel S., Rabchevsky A., Saito H.

Animal Study on Systemic / IV, published in Innov Aging (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Innov Aging (2017)
Reported sample size
—
Source database
Europe PMC
PMCID
PMC6183888

Abstract (original English)

Abstract Sepsis, a life-threatening condition accompanied by profound systemic inflammation, is a serious problem among the aging population as both susceptibility and mortality increase dramatically with age. Among survivors, >70% report muscle weakness for years after hospital discharge. Published studies aimed at elucidating the underlying mechanism for this phenomenon have been limited to analysis during sepsis due to the lack of an appropriate model (i.e. models are too severe and cause early death or are too mild to induce long-term weakness). Despite this limitation, these studies have consistently observed mitochondrial dysfunction during sepsis. The objective of the current study was to determine if mitochondria remained dysfunctional weeks after recovery from severe sepsis. Experimental sepsis was induced in 16-month-old mice by cecal slurry injection in combination with ICU-like interventions (antibiotic and fluid resuscitation). Two weeks later, mice were euthanized and mitochondria from the tibialis anterior (TA; fast-twitch) and soleus (slow-twitch) muscles were isolated and subjected to respiration analysis using Seahorse Biosciences technology. The maximum ATP phosphorylation rate was significantly reduced in the TA of survivors however State IV was unchanged, suggestive of increased electron leakage. State V-driven-Complex I activity was also reduced. No signif

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research